Anticancer-agent development: X-ray structure of dimethyl 2,3,4,5-tetrahydro-3-(3,4-methylenedioxybenzoyl)-2-oxo-5β-(3,4,5-trimethoxyphenyl)-3α,4α-furandicarboxylate

Anticancer-agent development: X-ray structure of dimethyl 2,3,4,5-tetrahydro-3-(3,4-methylenedioxybenzoyl)-2-oxo-5β-(3,4,5-trimethoxyphenyl)-3α,4α-furandicarboxylate